Sign in
Create a Profile
The Effects of ?-9-THC and Naloxone in Humans
Diseases and Conditions Researched
Healthy
What is the purpose of this trial?
The purpose of this project is to examine the effects of mu-opiate antagonism on the rewarding and reinforcing effects of delta-9-tetrahydrocannabinol (THC), the main psychoactive ingredient of cannabis.
Participation Guidelines
Gender: Both
This trial accepts healthy volunteers.
Click here for detailed participation information for this trial.
| Sponsor: | Yale University |
|---|---|
| Dates: | April 25, 2012 |
| Last Updated: | March 11, 2013 |
| Study HIC#: | 1108008940 |
| Clinicaltrials.gov ID: | NCT01591629 |
How will my information be used?
For more information about this trial, contact:
Ashley Schnakenberg
203-932-5711 ext 4485
ashley.schnakenberg@yale.edu
Principal Investigator
Deepak Cyril D''Souza
Psychiatry
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
